Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2013; 19(20): 3007-3017
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3007
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3007
Characteristics | Controls | CD | CD + Realsil | HFD | HFD + Realsil | Controls | HFD | HFD + Realsil |
day 30 | day 30 | day 30 | day 30 | day 30 | day 60 | day 60 | day 30 | |
Body weight (g) | 305 ± 8 | 311 ± 12 | 304 ± 11 | 302 ± 10 | 308 ± 12 | 355 ± 11 | 364 ± 13 | 351 ± 12 |
Liver weight (g) | 12.7 ± 0.5 | 19.7 ± 1.3a | 16.7 ± 0.7a | 15.7 ± 1.7a | 13.1 ± 1.3 | 12.7 ± 0.5 | 18.8 ± 1.1a | 15.1 ± 0.6ac |
ALT (IU/L) | 30 ± 8 | 92 ± 14a | 68 ± 12ac | 42 ± 10a | 31 ± 7c | 30 ± 8 | 69 ± 11a | 52 ± 8ac |
% area | 3 ± 2 | 311 ± 12 | 304 ± 11 | 16 ± 4 | 8 ± 3 | 4 ± 1 | 20 ± 4 | 15 ± 3ac |
No. of droplets | 11 ± 5 | 19.7 ± 1.3a | 16.7 ± 0.7a | 570 ± 47a | 356 ± 23 | 12 ± 6 | 389 ± 31a | 519 ± 26ac |
Mean droplet diameter | 1.1 ± 0.3 | 9.2 ± 1.4a | 6.8 ± 1.2ac | 4.2 ± 1.0a | 3.2 ± 0.7c | 0.9 ± 0.5 | 4.4 ± 1.1a | 3.4 ± 0.9ac |
Day 7 | Day 14 | Day 30 | ||
Glutathione | S | 34.3 ± 3.1 | 33.2 ± 1.4 | 25.3 ± 1.2a |
34.0 ± 1.3 nmol/mg prt | R | 35.1 ± 1.2 | 33.7 ± 1.0 | 30.9 ± 1.1ac |
Thioredoxin | S | 14.2 ± 1.0a | 16.3 ± 2.4a | 5.2 ± 0.7 |
5.6 ± 0.9 nmol/mg prt | R | 11.3 ± 1.0a | 14.4 ± 1.0a | 6.2 ± 0.7c |
Nitrosothiols | S | 32.9 ± 3.5a | 30.0 ± 2.2a | 13.0 ± 1.2a |
16.8 ± 4.7 pmol/mg prt | R | 35.4 ± 2.7a | 27.3 ± 2.2ac | 15.8 ± 1.5ac |
MDA-TBA | S | 17 ± 4a | 39 ± 8a | 92 ± 10a |
12 ± 3 nmol/L | R | 12 ± 3 | 19 ± 4ac | 41 ± 9ac |
Nitrosothiols | S | 73 ± 15 | 79 ± 12a | 88 ± 10a |
62 ± 10 nmol/L | R | 67 ± 10 | 69 ± 10 | 74 ± 11ac |
Nitrotyrosine | S | 6 ± 2 | 10 ± 3a | 14 ± 3a |
6 ± 1 nmol/L | R | 5 ± 1 | 5 ± 2c | 10 ± 2ac |
K-18 | S | 222 ± 21 | 233 ± 16a | 289 ± 20a |
198 ± 20 U/L | R | 210 ± 10 | 213 ± 13c | 240 ± 17ac |
GPx activity | S | 9.3 ± 1.2a | 21.1 ± 3.7a | 13.7 ± 1.8a |
4.5 ± 0.4 nmol NADH/min/mg prt | R | 6.3 ± 0.9a,b | 20.8 ± 1.4a | 16.6 ± 2.6a,b |
Day 14 | Day 30 | Day 60 | ||
Glutathione | S | 23.7 ± 1.9a | 20.8 ± 2a | 22.4 ± 2.4a |
33.4 ± 0.8 nmol/mg prt | R | 22.3 ± 1.8a | 23.9 ± 1.7a | 23 ± 1.6a |
Thioredoxin | S | 9.2 ± 0.9a | 8.9 ± 0.8a | 4.3 ± 1.0 |
5.4 ± 0.5 nmol/mg prt | R | 7.6 ± 0.7ac | 7.8 ± 0.7a | 7.4 ± 1.7ac |
Nitrosothiols | S | 18.1 ± 1.5 | 19.6 ± 2.5 | 10 ± 2.3a |
20.4 ± 3.1 pmol/mg prt | R | 14.4 ± 1.7ac | 16.1 ± 2.3a | 14.3 ± 1.9ac |
GPx | S | 4.7 ± 0.6a | 6.5 ± 1.3a | 4.6 ± 1.6 |
3.9 ± 0.3 nmol NADH/min/mg prt | R | 3.4 ± 0.5c | 4.3 ± 1.0c | 4.1 ± 1.0 |
- Citation: Grattagliano I, Diogo CV, Mastrodonato M, de Bari O, Persichella M, Wang DQ, Liquori A, Ferri D, Carratù MR, Oliveira PJ, Portincasa P. A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. World J Gastroenterol 2013; 19(20): 3007-3017
- URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3007.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3007